Influenza infections after hematopoietic stem cell transplantation [6]

Clinical Infectious Diseases

Volumn 41, Issue 2, 2005, Pages 273-274

  Machado, Clarisse M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFLUENZA; INFLUENZA VACCINATION; LETTER; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 21844464853     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/431304     Document Type: Letter

References (7)

1. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004;39:1300-6.
2. Doebbeling BN, Edmond MB, Davis CS, Woodin IR, Zeitler RR. Influenza vaccination of health care workers: evaluation of factors that are important in acceptance. Prev Med 1997; 26:68-77.
3. van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003;21: 1780-5.
4. Ministério da Saúde. Fundação Nacional da Saúde. O desafio da influenza: epidemiologia e organização da vigilância no Brasil. SVS-Boletim eletronico epidemiologico. Ano 04-no. 01. 2004. Available at: http://www.saude.gov.br/svs. Accessed 2 February 2004.
5. MW Link, AH Mokdad, L Elam-Evans, et al. Centers for Disease Control and Prevention (CDC). Estimated influenza vaccination coverage among adults and children-United States, September 1-November 30, 2004. MMWR Morb Mortal Wkly Rep 2004;53: 1147-53.
6. Machado CM, Boas LS, Mendes AV, et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004;34:111-4.
7. Machado CM, Mendes AVA, Vilas Boas LS, Rocha, IF, Pannuti CS. Clinical efficacy of influenza vaccination in bone marrow transplant recipients [abstract G-880]. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2003:279.